# Sequential Intravesical Gemcitabine and Docetaxel for Rescue Therapy in BCG Unresponsive Non-muscle Invasive Bladder Cancer Patients

> **NCT06374914** · — · UNKNOWN · sponsor: **Dokuz Eylul University** · enrollment: 120 (estimated)

## Conditions studied

- Bladder Cancer
- BCG
- Gemcitabine
- Docetaxel
- Intravesical Instillation

## Interventions

- **DRUG:** Intravesical Solution

## Key facts

- **NCT ID:** NCT06374914
- **Lead sponsor:** Dokuz Eylul University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-04-09
- **Primary completion:** 2026-04-09
- **Final completion:** 2026-04-09
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2024-04-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06374914

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06374914, "Sequential Intravesical Gemcitabine and Docetaxel for Rescue Therapy in BCG Unresponsive Non-muscle Invasive Bladder Cancer Patients". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06374914. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*